ArticleAntimicrobial agents and chemotherapy2017

Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats.

Jennifer L Hoover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.